Publication Date
In 2025 | 1 |
Since 2024 | 1 |
Since 2021 (last 5 years) | 1 |
Since 2016 (last 10 years) | 1 |
Since 2006 (last 20 years) | 2 |
Descriptor
Age Differences | 2 |
Attention Deficit… | 2 |
Drug Therapy | 2 |
Older Adults | 2 |
Patients | 2 |
Adults | 1 |
Clinical Diagnosis | 1 |
Comorbidity | 1 |
Comparative Analysis | 1 |
Correlation | 1 |
Databases | 1 |
More ▼ |
Author
Adler, Lenard | 1 |
Curtis Bone | 1 |
Destin Groff | 1 |
Durell, Todd | 1 |
James R. Latronica | 1 |
Kraig Holt | 1 |
Paczkowski, Martin | 1 |
Schuh, Kory | 1 |
Wen-Jan Tuan | 1 |
Wilens, Timothy | 1 |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
Conners Rating Scales | 1 |
What Works Clearinghouse Rating
Destin Groff; Wen-Jan Tuan; Kraig Holt; James R. Latronica; Curtis Bone – Journal of Attention Disorders, 2025
Introduction: Prescription stimulants are an effective FDA approved treatment for attention deficit hyperactivity disorder (ADHD) however their safety has come under scrutiny. Multiple studies demonstrate safe use in pediatric populations, but prescriptions are increasing to adults and it is not evident which comorbidities might place people at…
Descriptors: Heart Disorders, Stimulants, Attention Deficit Hyperactivity Disorder, Drug Therapy
Durell, Todd; Adler, Lenard; Wilens, Timothy; Paczkowski, Martin; Schuh, Kory – Journal of Attention Disorders, 2010
Objective: Atomoxetine is a nonstimulant medication for treating child, adolescent, and adult ADHD. This meta-analysis compared the effects in younger and older adults. Method: A post hoc analysis was conducted using data from two double-blind, placebo-controlled clinical trials. Data from patients aged 18-25 years were compared with data from…
Descriptors: Rating Scales, Older Adults, Patients, Effect Size